OEC and the Promise of Therapeutic Imaging
In a land of multi-modality imaging giants, OEC has more than held its own with a highly focused niche strategy. Advances in minimally-invasive surgery should further boost OEC, which offers surgeons a different kind of visualization solution. Now OEC has to convince investors of the value of steady, if unspectacular, growth.
You may also be interested in...
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.
The regulatory tools are for use in medical device development.
The US agency plans to hold a virtual workshop that will use breakout sessions to get stakeholder feedback on specific hurdles preventing more pediatric devices coming to market.